Selexis SA and Berkeley Lights, Inc. today announced a collaboration around the acquisition of Berkeley Lights’ Beacon® optofluidic platform. The partners will leverage the technology to accelerate ...

EMERYVILLE, Calif., April 24, 2025--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American Association for ...

Cell lines are invaluable tools for the biopharmaceutical industry, used to generate a range of therapeutic classes, from proteins such as antibodies to vaccines. As both the demand for ...

Biopharmaceutical manufacturers must consider a surprisingly wide range of factors when deciding where to turn for assistance with cell line development. Biopharmaceuticals are revolutionizing the way ...

To achieve this progress, biologic production has had to reinvent itself. Although biologics were once sourced directly from donated blood plasma or cells, the backbone of this process is now a ...